— Latest update: July 2022 —
Quasi-drugs are medicines for the purpose of prevention of symptoms and hygiene: they have a weaker effect on the human body than medicines. Some products, such as nutritional drinks, shampoos, and hair-growth products, are considered “quasi-drugs”, whereas skincare products that are less effective than “quasi-drugs” are classified as cosmetics.
This different category of products, which doesn't have an EU counterpart, imply vastly different standards and regulations than other pharmaceutical products. Pre-marketing approvals, registration of ingredients and means of manufacturing are highly regulated for these over-the counter products. Thus, EU companies need to consider a variety of new aspects for their implementation on the Japanese market.
> For more information on Cosmetics, please visit our specific sectorial page
What are the opportunities and risks to enter the growing market of telemedicine in Japan?The Japanese telemedicine market is anticipated to grow. The potential of telemedicine for the development of
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.